The deadly synergy of HIV and tuberculosis.
D044966:Anti-Retroviral Agents / Q000191:economics / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D014943:Global Health; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D006291:Health Policy; D006801:Humans; D007182:Income; D007538:Isoniazid / Q000627:therapeutic use; D011203:Poverty; D013019:South Africa / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology* / Q000517:prevention & control; D014944:World Health Organization
D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents; D007538:Isoniazid